These findings further support that CRP2 and SRF function interdependently and cooperate in driving the expression of pro-invasive MMPs in breast cancer cells, exacerbating the clinical outcome of patients by enhancing metastasis. The gene discussed is CRIP2; the disease is breast cancer.